@iScienceLuvr: CancerBench: the frontier model cancer cure benchmark. AI lab CEOs keep talking about curing cancer, so I made a benchm…
Summary
A satirical benchmark called CancerBench tracks the number of cancer types cured by AI models, highlighting claims from AI leaders while all models remain at zero cures.
View Cached Full Text
Cached at: 09/12/26, 12:45 AM
CancerBench: the frontier model cancer cure benchmark.
AI lab CEOs keep talking about curing cancer, so I made a benchmark.
One metric: how many types of cancer has your model cured?
All models are currently tied at zero.
It’s time to hillclimb!
https://t.co/SeEJz0FFYv https://t.co/GmOvBiKrEE
CancerBench — The frontier-model cancer cure benchmark
Source: https://cancerbench.com/ Cancer types curedAll tied for first. And last.IN THEIR OWN WORDS
AI leaders on curing cancer.
Sep 6, 2025 – Sep 6, 2026
ReportedAug 20, 2026
“AI will do it”
On X, Musk replied to a post about Amodei’s call for AI companies to prove themselves by curing cancer.
ReportedAug 16, 2026
“The thing that will work is actually curing cancer.”
Dario Amodei
Co-founder & CEO, Anthropic
Discussing public trust, Amodei acknowledged that AI companies had yet to deliver their promised benefits and called for results.
Interview publishedApr 7, 2026
“[H]umanity could benefit from the proceeds of that, like cures for cancer …”
Demis Hassabis
Co-founder, Google DeepMind
Speaking with Cleo Abram, Hassabis described developing focused scientific AI systems alongside AGI. The interview was recorded March 5.
Davos sessionJan 20, 2026
“It will help us cure cancer.”
Dario Amodei
Co-founder & CEO, Anthropic
At Davos, Amodei described the benefits he expected from powerful AI, while also warning about serious risks.
Interview publishedJan 13, 2026
“… trying to cure cancer through drug discovery …”
Reid Hoffman
Co-founder, LinkedIn & Manas AI
Asked what excited him about 2026, Hoffman pointed to Manas AI’s ambitions. He also acknowledged that some AI expectations were overhyped.
ReportedSep 24, 2025
“[Y]ou could choose to cure cancer by having AI do a bunch of research …”
Sam Altman
Co-founder & CEO, OpenAI
Arguing for more computing capacity, Altman contrasted using AI for cancer research with offering free education worldwide.
Selected excerpts with context.
Similar Articles
AI isn’t close to curing cancer. This startup says it knows what it will take.
Biotech startup Vivodyne claims current AI models lack sufficient human tissue data for effective drug discovery and has developed robotic labs called HIVE to generate this data, aiming to improve preclinical testing for diseases like cancer.
Introducing HealthBench
OpenAI introduces HealthBench, a new benchmark for evaluating AI systems in healthcare contexts, created with 262 physicians across 60 countries. The benchmark includes 5,000 realistic health conversations with physician-written rubrics to assess model performance on meaningful, trustworthy, and improvable metrics.
AI is finally curing cancer
AI technology is showing promising advancements in treating cancer, potentially marking a major breakthrough in healthcare.
@Lyubh22: Coding benchmarks are saturating. AI4Research is the next frontier. Thrilled to see our MLS-Bench (https://mls-bench.co…
Announcing MLS-Bench, the first AI4Research benchmark to gain broad community adoption, testing AI agents on 140 executable tasks across 12 domains to propose modular ML improvements. The post includes leaderboard scores for models like Claude Opus 4.6 and GPT-5.4.
Introducing LifeSciBench
OpenAI introduces LifeSciBench, a benchmark of 750 expert-authored tasks to evaluate AI systems on realistic life science research workflows, including evidence handling, analysis, and scientific reasoning.